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Background: Studies in adults with major depressive disorder (MDD) have implicated dysregulation of frontal-
limbic circuits in the symptomology of this disorder. We hypothesized that the middle frontal gyrus (MFG; a core
portion of the dorsolateral prefrontal cortex or DLPFC) and the anterior cingulate (caudal), regions implicated in
emotive and cognitive control, would display a reduced cortical thickness in youth with MDD as compared to
healthy, non-depressed adolescents.
Methods: Sixteen healthy control adolescents (17.19 ± 1.87 years; 7 males, 9 females) and thirty MDD participants
(16.89 ± 2.01 years; 9 males, 21 females) underwent magnetic resonance imaging (MRI). Cortical thickness analysis
was carried out using FreeSurfer software.
Results: Counter to our hypothesis, we observed thicker right and left rostral MFG in MDD adolescents as
compared to controls (p = 0.004 and p = 0.005, respectively). Furthermore, the left caudal anterior cingulate cortex
was thicker in MDD subjects as compared to controls (p = 0.009). In MDD subjects, there was a significant inverse
correlation between age and left MFG thickness (r = -0.45, p = 0.001).
Conclusions: These results have implications for the developmental trajectory of the frontal lobe in adolescent
MDD. The MFG is implicated in the frontal-limbic circuits underlying executive functioning and their interaction with
affective processing. Alterations in this region are likely involved with the symptoms of MDD. Limitations include a
small sample size and cross sectional design.
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Brain regions known to be associated with emotional
regulation [1] are also implicated in the pathophysiology
of major depressive disorder (MDD) in both adults and
youth [2-8]. Neuroanatomical and functional distur-
bances within frontal and limbic regions, as well as their
connective circuits, have been consistently noted in
MDD, leading to the frontal limbic model of MDD [9].
Specifically, altered functioning of the anterior cingulate
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reproduction in any medium, provided the orand the orbitofrontal cortex (OFC) [10], which are con-
nected with striatal and limbic structures, has been impli-
cated in MDD. Abnormalities in these areas can impair
many executive functions including attention, planning,
and performance monitoring [10]. Dorsal ACC-containing
circuits are thought to be involved in self-evaluation, while
the DLPFC is involved in processes like behavioral adjust-
ment and attention [10]. Neurophysiological and/or ana-
tomical changes in these regions may underlie the
cognitive deficits evident in MDD.
Brain imaging studies have observed differences be-
tween depressed and healthy comparison participants in
these regions. Magnetic resonance spectroscopy (MRS)
studies of the DLPFC have shown altered choline con-
centrations in elderly MDD patients [11,12], as well as
in pediatric depressed patients [13]. Mayberg et al. [14]al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Table 1 Demographic characteristics (Mean ± standard
deviation)
Item Controls MDD
Age (Years) 17.19 ± 1.87 16.89 ± 2.01
Sex 7 males 9 males
9 females 21 females
CDRS 38.87 ± 11.701 66.53 ± 14.43
BDI 1.81 ± 1.52 18.93 ± 12.98
Duration of Illness (Months) - 35.31 ± 21.28
CDRS – Children’s Depression Rating Scale, BDI – Beck Depression Inventory.
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rest, and found increased glucose metabolism in the
right DLPFC [14]. In a functional magnetic resonance
imaging (fMRI) study by Grimm and colleagues [15], a
decrease in the blood oxygen dependent level (BOLD)
signal was observed in the left DLPFC during expected
and unexpected emotional judgment of photographs,
and an increase in the right DLPFC during expected
emotional judgment by depressed participants. To date,
few studies have investigated volumetric and cortical
thickness in the DLPFC in depressed youth [16] to see if
these functional changes are reflected morphologically.
Abe and colleagues [17] assessed gray matter volume of
the prefrontal cortex in adults with MDD and noted
smaller gray matter volumes in the bilateral middle
frontal gyri in these individuals [17]. Non-remitting
MDD adults also displayed a reduction in gray matter
volume in the DLPFC [18]. Post mortem work in MDD
supports these neuroimaging findings [19,20]. Peterson
et al. [21] found a reduction cortical thickness across a
large expanse of the lateral right cerebral hemisphere
(including the DLPFC) in people at high risk for devel-
oping MDD. In summary, data from imaging studies
show alterations in DLPFC function, structure and
chemistry in MDD. More recently, differences in cortical
thickness of the ACC have been noted in MDD (i.e.,
thinner medial orbital prefrontal cortex, thicker tem-
poral pole an caudal ACC) [22] and in people at risk for
developing MDD (i.e., thinner right cerebral hemisphere
in persons at high risk) [21].
Finally, development itself may play a role in the dis-
order and adolescence is a time of special vulnerability
for developing mood disorders. Physiologically, regions
involved in emotional and stress regulation undergo tre-
mendous changes during adolescence. The prefrontal
cortex, hippocampus, amygdala, hypothalamus and pitu-
itary demonstrate marked developmental trajectories
[23-27] and the DLPFC is one of the last brain regions
to reach maturity [28,29]. Disruptions in the normal de-
velopment of these brain regions may lead to altered,
and perhaps maladaptive, stress responses and associated
mood disorders. Indeed, it may be that adolescents with
MDD are on a different developmental trajectory than
healthy youth.
In the current study, we examined cortical thickness
in adolescents with MDD and healthy adolescent con-
trols. To date, there has only been one previous report
of cortical thickness in children and adolescents with
MDD [16]. Cortical thickness was examined as it is sen-
sitive to both the columnar architecture of the cortex
(i.e., it spans the cortical layers) and developmental
changes in normally developing and clinical populations
[30-32]. We hypothesize that the children and adoles-
cents with MDD will have thinner cortices in the middlefrontal gyrus (MFG; a core portion of the DLPFC), and
ACC.Methods
Subjects
A total of 52 participants were recruited for this study
(See Table 1). Adolescent MDD participants were re-
cruited from hospitals, physician offices and universities in
the area. Healthy control adolescent participants were re-
cruited through advertising. A clinical interview and
investigator-rated Kiddie-SADS-Present and Lifetime Ver-
sion (K-SADS) then confirmed diagnoses of MDD in the
affected group and classification of the healthy control
participants, based on DSM-IV criteria [33]. Subject symp-
tomology information was gathered using the Children’s
Depression Rating Scale (CDRS)[34,35] and the Beck
Depression Inventory (BDI). With the exception of three
patients with psychiatric comorbidities, all participants
were physically healthy, with IQ in the normal range
(mean +/- SD) IQs and no other intellectual disorders.
One MDD participant was comorbid for oppositional defi-
ant disorder (ODD) and two suffered from substance
abuse. At the time of the MRI scan, all but four MDD par-
ticipants were treatment-naive. The four participants on
pharmaceutical treatment prior to testing had only started
the treatment within two weeks of the MRI scan. Two
participants were taking sertraline [a selective serotonin
reuptake inhibitor (SSRI)], one was taking moclobemide
(reversible monoamine oxidase inhibitor), and the fourth
was taking dextroamphetamine (psychostimulant). Exclu-
sion criteria for participation in this study were: a history
of neurological illness, medical illness, claustrophobia, >21
year of age, or the presence of a ferrous implant or pace-
maker. Six MRI scans were not used in the data analyses
due to poor scan quality. Unless stated otherwise, the
means and standard deviations are presented for all mea-
sures. The final sample consisted of 16 controls and 30
MDD patients (see Table 1). All participants and their
legal guardian provided written informed consent prior to
the start of the study in accordance with the Research Eth-
ics Board (REB) of the IWK Children’s Hospital and in
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wma.net/en/30publications/10policies/b3/index.html).MRI acquisition protocol
MRI scans were conducted with a 1.5 Tesla Siemens
Magnetom Vision magnetic resonance system. A sagittal
scout series was acquired to test image quality. A three-
dimensional fast low angle shot (FLASH) sequence was
used to acquire data from 124 1.5 mm-thick contiguous
coronal slices through the entire brain (echo time = 5 ms,
repetition time = 25 ms, acquisition matrix = 256 × 256
pixels, field of view = 24 cm and flip angle = 40°).Cortical thickness analysis
Each MRI dataset underwent cortical surface reconstruc-
tion via the FreeSurfer automated cortical measurement
technique. FreeSurfer is a free software program that
can be downloaded (http://surfer.nmr.mgh.harvard.edu).
Procedures for using the FreeSurfer program have been
outlined in various sources [36-38]. First, the cortical
surface undergoes reconstruction involving the correc-
tion of intensity variations that exist between MRI data
sets due to variations in the magnetic field during the
scanning procedure [36]. This reconstruction also in-
volves the removal of any voxels containing the skull or
other extra-cerebral entities [36]. After the intensity cor-
rections and skull stripping, a researcher blind to the
condition of each subject manually corrected the images.
Subsequently, the individual data sets underwent a seg-
mentation procedure based on a structural estimation of
the gray-white matter interface [36]. In order to generate
a smooth and accurate representation of both the pial
surface and the gray-white interface, a triangular tessel-
lation cover was applied to each scan, which was then
inflated [36]. Inflation allows for easier visualization by
reducing any interference by folding so that the cortical
area within sulci can be visualized [38]. Scans were then
aligned with the reference brain template based on the
positioning of the gyri and sulci [38]. It is generally diffi-
cult to establish a coordinate system in which the cortical
surfaces of different volumes can be accurately matched
to provide consistent measurements [38]. Therefore, the
reconstructed cortical surfaces were transformed into
parameterizable surfaces. Parameterization provides a
reproducible and consistent coordinate system [38]. Fi-
nally, the average cortical thickness measurements were
taken at every point on the smoothed and aligned images
[37]. Cortical thickness is calculated by averaging the dis-
tance between the pial surface and the gray-white inter-
face [37]. It is important to note that this technique for
taking automated cortical thickness measurements is not
restricted by the resolution of the voxels in the original
MRI data and can provide measurements accurate to asub-millimeter scale [37]. For this study we restricted our
focus to MFG and caudal ACC.Statistical analysis
Statistical analyses were conducted with the Statistical
Package for Social Sciences (SPSS) software. The Levine’s
test of variance was violated when analyzing the variance
between the two study groups for the MFG (left and right:
p < 0.001). Therefore, a non-parametric Mann-Whitney U
test was used to analyze planned comparisons (aspects of
the MFG and caudal ACC) of cortical thickness between
the groups. In order to account for multiple comparisons,
p was set at 0.01 [39]. Spearman correlations, exploratory
in nature, were performed between cortical thickness and
age, symptom severity, duration of illness and age of onset
(for MDD patients).Results
Main findings
There was no age difference between the two groups (t =
1.32, df = 51, p = 0.19). Mann-Whitney U-tests revealed the
right and left MFG were thicker in MDD participants than
in controls (p = 0.004 and p = 0.005 respectively; Right -
controls: 2.35 ± 0.17, MDD= 2.68 ± 0.41; Left – controls:
2.34 ± 0.11, MDD: 2.65 ± 0.39), contrary to our hypothesis
(Figure 1). Furthermore, the left, but not right, caudal ACC
was thicker in MDD participants than in controls (p =
0.009; Left - controls: 2.74 ± 0.28, MDD: 2.94 ± 0.25;
Figure 2; Right - controls: 2.77 ± 0.26, MDD: 2.80 ± 0.28).
When medicated MDD participants were removed (N = 4),
the results persisted (right rostral MFG: p = 0.002; left ros-
tral MFG: p = 0.005; left caudal ACC: p = 0.008). Dropping
the MDD participants with comorbidity did not signifi-
cantly alter the results (right rostral MFG: p = 0.001; left
rostral MFG: p = 0.001; left caudal ACC: p = 0.012). Given
the unexpected nature of the results, we examined the vol-
ume output provided by FreeSurfer. Volume for the right
and left MFG and left caudal ACC did not differ between
groups, not did volume and thickness correlate between
these regions as well. It should also be noted that removal
of the two subjects with a history of substance abuse did
not change the results.Correlations
In MDD subjects there was an inverse correlation be-
tween age and rostral MFG cortical thickness (trend for
the right: r = -0.34, p = 0.07; significant for the left:
r = -0.45, p = 0.01). No further correlations were found
to be significant (cortical thickness and clinical variables
like symptom severity, duration of illness, etc.). No sig-











































Figure 1 Mean cortical thickness of the right and left rostral middle frontal gyrus (mm). Error bars indicate standard deviation. Stars
indicate significance (*p = 0.004, **p = 0.005).
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In an exploratory analysis, considering the small sample
size, we examined the effect of gender on the results. In
the right and left rostral MFG the effect of group on cor-
tical thickness held for females (p = 0.002 and p = 0.02,
respectively) but not males. However, in the caudal
ACC, the group effect noted in the left side was only
seen in males (p = 0.02). Within each group, there was
no difference between males and females in rostral MFC






























Figure 2 Mean cortical thickness of the right and left caudal anterior
significance (*p = 0.009).Volume and surface area differences
In an exploratory analysis, we also examined surface area
and volume. Rostral MFC and caudal ACC did not differ
between groups on these measures.
Discussion
Counter to our hypothesis, our results indicate greater
cortical thickness in the MFG in children and adoles-
cents with MDD compared with healthy controls. Add-







cingulate (mm). Error bars indicate standard deviation. Stars indicate
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data reported by van Eijndhoven et al. [22,40] and Peterson
et al. [21]. These group effects appeared to display some
sex-specific effects. The implications of these results are
discussed below.
The rostral middle frontal gyrus (MFG) is partially lo-
cated in the dorsolateral prefrontal cortex (DLPFC) [41].
Brodmann’s area (BA) 46 makes up most of the rostral
MFG, but it includes portions of BA 9 and BA 10, which
comprise the DLPFC [41]. The rostral MFG is recipro-
cally connected to many brain regions [42]. Direct in-
puts and outputs include: the cingulate cortex, thalamus,
orbitomedial prefrontal cortex, and posterior association
cortex. Efferents connect to the hippocampus, but the
DLPFC does not receive any direct input from this area.
Indirect inputs to the lateral prefrontal cortex include
the amygdala via the hippocampus, thalamus, cingulate
cortex and the orbitomedial prefrontal cortex [42,43].
The connections and interactions of the DLPFC with
other brain structures are consistent with its involve-
ment in various complex executive functions. For in-
stance, BA 46 and BA 9, and the lateral prefrontal cortex
in general, have been implicated in working memory
[44], a process often impaired in MDD [45-47]. As previ-
ously noted, alterations in prefrontal areas can also
impair many executive functions including attention,
planning, monitoring of performance, mood regulation
and behavioral adjustment; all of can be disrupted in
MDD [10,43].
As previously noted, many studies have indicated alter-
ations in the DLPFC in MDD; from MRS studies
[11-13,48], to functional imaging [14,15] and structural
and cytoarchitectural research [17,49,50]. Abe and col-
leagues [17] found a decrease in the bilateral MFG vol-
ume in adult MDD patients. Their findings combined
with our results, suggests that the MFG may be a locus
of neuronal change in the context of MDD. However, it
is important to note that cortical volume does not cor-
relate with cortical thickness; a cortex with a smaller
volume could indeed have a larger cortical thickness.
Our finding of increased cortical thickness represents a
novel finding in individuals affected by MDD. Neverthe-
less, post-mortem investigations of neuronal and glial
size and density support our results given the inverse
correlation noted between thickness and age in DLPFC
in MDD participants. Both Rajkowska and colleagues
[50] and Cotter and colleagues [49] found reduced size
and density of both neurons and glia in the DLPFC in
adults with MDD. These changes in cytoarchitecture
and DLPFC volume could result from truncated pruning
and/or reductions in pre-programmed cell loss during
development. Pruning is essential in brain development
as it limits lateral inhibition and eliminates redundant/
un-needed connections. Our finding of an increase incortical thickness that is negatively correlated with age
may indicate an altered developmental trajectory than in
non-depressed controls, which may exhibit characteristic
pruning during development resulting in lower volumes,
thinner cortices, and decreased function in the DLPFC.
In people at risk for developing MDD, a thinner DLPFC
was also noted [21]. The sample for that study was
weighted towards adults (18% were children) and no
interaction with age was detected. Cortical thickness of
the DLPFC is influenced by the age of onset [51] and
this may be responsible for the discrepancy noted here.
Further longitudinal studies are warranted, especially in
high-risk samples that develop clinical MDD.
The ACC resides in the medial frontal cortex [52] and
encompasses BA 25, BA 24 and BA 32 [53]. The ACC
has connections with various brain areas including the
limbic system, which is critically implicated in affect
[54]. Abnormal functioning of the ACC is thought to
occur in anhedonia, a characteristic feature of MDD
[54,55]. Neuroimaging studies have shown that the ACC
is also involved in many overlapping processes as the
DLPFC including working memory, language, attention
and information processing [54]. The role of the ACC in
conflict monitoring is believed to have a role in motiv-
ational and emotional responses, which are also altered
in MDD [55]. It has been hypothesized that there is
hyper-responsivity in conflict monitoring centers in
MDD [55]. In depressed individuals, there is heightened
ACC activity during reward anticipation [52,55]. In a
study performed by Knutson et al. [56], the dorsal ACC
displayed hyper-activation in depressed individuals dur-
ing anticipation of a monetary reward. Our results sup-
port the finding that the ACC is over-active in youth
with MDD. The caudal ACC was found to be thicker in
MDD subjects, which suggests an increase in cell num-
ber and/or density. This increase could play a role in the
hyperactivity evident in MDD.
Various studies have indicated that extensive neural
pruning takes place in healthy adolescents [57-59]. The
thicker cortex that was found in the rostral MFG and cau-
dal ACC could reflect deficient neural pruning in de-
pressed adolescents. MDD may be more likely in
individuals with DLPFC and ACC underdevelopment
(i.e., inefficient pruning) during adolescence. On their face,
our finding of thicker cortex in the MFG and left caudal
ACC seem to contradict findings observed in adults. The
relationship with age in MDD adolescents may explain
this difference. However, no correlations between cortical
thickness and illness duration, age of onset, or symptom
severity in adolescents with MDD emerged in the present
study. Though this could indeed reflect the absence of a
relationship between these variables, it is more feasible
that these null effects were influenced by the small sample
size and the cross-sectional nature of the study.
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tical thickness of right and left rostral MFG were evident
in females with MDD, but not in affected males. In the
left caudal ACC, affected males were found to display re-
duced thickness not seen in affected females. This sug-
gests differential regional neurodevelopment in males
and females, an indication of divergent neurobiological
substrates MDD in the two sexes. However, our sample
size is relatively limited, thus, it is important that this
finding is replicated.
The FreeSurfer program used in the current study is a
reliable method for measuring cortical thickness [37].
However, FreeSurfer has not been validated for use in a
pediatric population. As a result, the measurements
attained in this study may not be representative of the ac-
tual cortical thicknesses in these subjects. Additionally,
the four medicated participants could have influenced our
cortical thickness outcomes. However, given that medica-
tion was used for a maximum of two weeks prior to the
MRI scan, substantial medication-induced changes in
cortical thickness were unlikely in this short time frame.
Another limitation of the study is the sample size. Replica-
tion with a larger, more diverse sample is warranted.
Finally, our study is limited by using a cross-sectional
paradigm. Longitudinal analyses of cortical thickness and
other neuroanatomical and functional parameters should
be conducted into adulthood to gain a complete under-
standing of the implications of MDD as a developmental
disorder.Conclusions
Due to the debilitating nature of MDD, it is imperative
that the neurobiological underpinnings of this disorder
be understood. To our knowledge, ours is the second
study investigating cortical thickness in adolescent MDD
patients. Previously, no significant differences in DLPFC
or ACC cortical thicknesses were noted between MDD
and control participants [16]. However, in the study by
Fallucca and colleagues, the majority of the MDD partic-
ipants had comorbid disorders including attention deficit
hyperactivity disorder (ADHD), ODD and anxiety disor-
ders [16], which could account for the differences in re-
sults. These discrepancies also highlight the need for
further studies on cortical thickness in pediatric/adoles-
cent MDD.
Future studies should include a larger sample size of
both depressed and control subjects. It is important that
MDD participants be treatment naive, and have limited
comorbidity. To further validate the measurements ob-
tained with the FreeSurfer program, it is important that
this technique and others be validated for use on the
pediatric population. Most importantly, in order to gain
a true understanding of the developmental mechanismof MDD, it is imperative that longitudinal analyses of
MDD patients be conducted throughout development.
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